|
Drugs and Chemicals of
Concern > Spice
Cannabinoid > CP 47,497 and homologues
CP 47,497 and homologues
2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol)
[Purported Ingredient of "Spice"]
July 2009
DEA/OD/ODE
Introduction:
CP 47,497 is a synthetic cannabinoid agonist without the
classical cannabinoid chemical structure. It is used in scientific research as
a tool to study the cannabinoid system. CP 47,497 homologues were recently
purported to be found in the herbal mixture "Spice", sold in
European countries mainly via internet shops. Although CP 47,497 is likely to
have similar effects in humans as Δ9-tetrahydrocannabinol (Δ9-THC),
the main active ingredient of marijuana, CP 47,497 and its homologues are not
controlled substances in the U.S.
Licit Uses:
CP 47,497 is used in basic scientific research to identify
cannabinoid receptors in the brain and study Δ9-THC’s mechanisms of
action.
Chemistry:
3-(4-(1,1-Dimethylheptyl)-2-hydroxyphenyl) cyclohexanol; cis-3-[2-hydroxy-4(1,1-dimethylheptyl)
phenyl]-cyclohexan-1-ol); IUPAC Name: 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol)
or CP 47,497 [Chemical Abstract Service (CAS) Registry Number 70434-82-1] is
identified to have some structural similarities to tetrahydrocannabinols (THC)
contained in Cannabis sativa L. (marijuana); but its chemical structure
is altered such that it is not classified as a THC. Further, the chemical
structure of CP 47,497 does not identify it as belonging to any class of
substances controlled under the Controlled Substances Act (CSA).
The chemical structures for CP 47,497(n=5) and side chain
homologues of CP 47,497(n=4, 6, or 7) (left) and Δ9-THC (right), a
compound representative of THC substances that occur in marijuana, are shown
below.

Based on the structural analysis, CP 47,497, is not
categorized as a THC substance but shares some structural features common to
the THC substances, such as Δ9-THC.
Pharmacology:
Behavioral pharmacology studies show that CP 47,497 has
Δ9-THC-like activity in animals. In mice, it decreases overall activity,
produces analgesia, decreases body temperature and produces catalepsy.
Together, these four effects are used by scientists to predict Δ9-THC-like
psychoactivity in humans. CP 47,497’s activity in all four tests suggests
that it is likely to have Δ9-THC-like psychoactive effects in humans.
In drug discrimination studies in rats, CP 47,497
generalized to Δ9-THC, i.e. produced subjective effects similar to those
of Δ9-THC.
In vitro studies show that CP 47,497 binds to both the
brain cannabinoid receptor CB1 and the peripheral cannabinoid receptor CB2
with higher affinity than Δ9-THC suggesting that it would have the same
effects as THC in vivo.
A search in the literature yielded no published studies of
the effects of CP 47,497 in humans.
A search in the literature yielded no published studies of
the pharmacological activity of the CP 47,497 side chain homologues in vitro,
in vivo, or in clinical settings.
Illicit Uses:
CP 47,497 homologues are purported to be present in the
herbal mixture "Spice" which may be smoked for its psychoactive
effects. No information on the illicit use of CP 47,497 or its homologues in
the U.S. is available at this time.
User Population:
Information on user population in the U.S. is very limited
and includes information from drug user internet forums. CP 47,497 abuse is
not monitored by any national drug abuse surveys.
Illicit Distribution:
The System to Retrieve Drug Evidence (STRIDE), a federal
database for the seized drugs analyzed by DEA forensic laboratories, and the
National Forensic Laboratory System (NFLIS), a system that collects drug
analysis information from state and local forensic laboratories, do not
contain reports of CP 47,497. Seizures of herbal mixtures called
"Spice" were reported in Ohio and Florida. "Spice" is
purported to contain substances that are similar in pharmacological activity
to Δ9-THC, including CP 47,497 and its homologues.
Control Status:
CP 47,497 and its homologues are not currently controlled
under the CSA.
Comments and additional information are welcomed by the
Drug and Chemical Evaluation Section, Fax 202-353-1263, telephone
202-307-7183, or E-mail ODE@usdoj.gov.
o:030909
|